Pharmafile Logo
Pharmafocus logo
Advanced Search

Isis Pharma

Showing 2 posts of 2 posts found.

AZ sign

AstraZeneca and Isis Pharma in $65m drugs collaboration

August 3, 2015
Manufacturing and Production, Research and Development AstraZeneca, Isis Pharma, Isis Pharmaceuticals, antisense, drug R&D

Isis Pharmaceuticals and AstraZeneca have announced a strategic collaboration to discover and develop antisense therapies for cardiovascular, metabolic and renal …

News

Biogen inks $299m deal for rare genetic disorder drug

January 5, 2012
Research and Development, Sales and Marketing Biogen, Isis Pharma

Biogen has signed a new deal with drug discovery firm Isis for its spinal muscular atrophy drug ISIS-SMNRx. Biogen will pay …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025